115 related articles for article (PubMed ID: 32747747)
21. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
Gori S; Rimondini S; De Angelis V; Colozza M; Bisagni G; Moretti G; Sidoni A; Basurto C; Aristei C; Anastasi P; Crinò L
Oncologist; 2007 Jul; 12(7):766-73. PubMed ID: 17673608
[TBL] [Abstract][Full Text] [Related]
22. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.
Gonzalez-Angulo AM; Cristofanilli M; Strom EA; Buzdar AU; Kau SW; Broglio KR; Smith TL; Hortobagyi GN
Cancer; 2004 Oct; 101(8):1760-6. PubMed ID: 15386311
[TBL] [Abstract][Full Text] [Related]
23. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
[TBL] [Abstract][Full Text] [Related]
24. High frequency of complex TP53 mutations in CNS metastases from breast cancer.
Lo Nigro C; Vivenza D; Monteverde M; Lattanzio L; Gojis O; Garrone O; Comino A; Merlano M; Quinlan PR; Syed N; Purdie CA; Thompson A; Palmieri C; Crook T
Br J Cancer; 2012 Jan; 106(2):397-404. PubMed ID: 22187033
[TBL] [Abstract][Full Text] [Related]
25. Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.
Leyland-Jones B
J Clin Oncol; 2009 Nov; 27(31):5278-86. PubMed ID: 19770385
[TBL] [Abstract][Full Text] [Related]
26. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
27. Metastatic patterns of breast cancer subtypes: what radiologists should know in the era of personalized cancer medicine.
Chikarmane SA; Tirumani SH; Howard SA; Jagannathan JP; DiPiro PJ
Clin Radiol; 2015 Jan; 70(1):1-10. PubMed ID: 25300558
[TBL] [Abstract][Full Text] [Related]
28. Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases.
Higashi H; Fukutomi T; Watanabe T; Adachi I; Narabayashi M; Shibui S; Hokamura N; Akashi-Tanaka S
Breast Cancer; 2000; 7(2):153-6. PubMed ID: 11029788
[TBL] [Abstract][Full Text] [Related]
29. Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
Laakmann E; Witzel I; Fasching PA; Rezai M; Schem C; Solbach C; Tesch H; Klare P; Schneeweiss A; Salat C; Zahm DM; Blohmer JU; Ingold-Heppner B; Huober J; Hanusch C; Jackisch C; Reinisch M; Untch M; von Minckwitz G; Nekljudova V; Müller V; Loibl S
Breast Cancer Res; 2019 May; 21(1):60. PubMed ID: 31077239
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of central nervous system metastases from breast cancer.
Chang EL; Lo S
Oncologist; 2003; 8(5):398-410. PubMed ID: 14530493
[TBL] [Abstract][Full Text] [Related]
31. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.
Miller KD; Weathers T; Haney LG; Timmerman R; Dickler M; Shen J; Sledge GW
Ann Oncol; 2003 Jul; 14(7):1072-7. PubMed ID: 12853349
[TBL] [Abstract][Full Text] [Related]
32. Pattern of metastasis and outcome in patients with breast cancer.
Gerratana L; Fanotto V; Bonotto M; Bolzonello S; Minisini AM; Fasola G; Puglisi F
Clin Exp Metastasis; 2015 Feb; 32(2):125-33. PubMed ID: 25630269
[TBL] [Abstract][Full Text] [Related]
33. Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
Montagna E; Cancello G; D'Agostino D; Lauria R; Forestieri V; Esposito A; Silvestro L; Accurso A; De Placido S; De Laurentiis M
Cancer Chemother Pharmacol; 2009 Jan; 63(2):275-80. PubMed ID: 18379783
[TBL] [Abstract][Full Text] [Related]
34. CNS metastases in breast cancer patients: prognostic implications of tumor subtype.
Bachmann C; Schmidt S; Staebler A; Fehm T; Fend F; Schittenhelm J; Wallwiener D; Grischke E
Med Oncol; 2015 Jan; 32(1):400. PubMed ID: 25433950
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system metastasis in breast cancer.
Boogerd W
Radiother Oncol; 1996 Jul; 40(1):5-22. PubMed ID: 8844883
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system metastases in women after multimodality therapy for high risk breast cancer.
Carey LA; Ewend MG; Metzger R; Sawyer L; Dees EC; Sartor CI; Moore DT; Graham ML
Breast Cancer Res Treat; 2004 Dec; 88(3):273-80. PubMed ID: 15609130
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge.
Stemmler HJ; Heinemann V
Oncologist; 2008 Jul; 13(7):739-50. PubMed ID: 18614587
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for central nervous system metastasis in patients with metastatic breast cancer.
Sezgin C; Gokmen E; Esassolak M; Ozdemir N; Goker E
Med Oncol; 2007; 24(2):155-61. PubMed ID: 17848738
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review.
Cormio G; Maneo A; Parma G; Pittelli MR; Miceli MD; Bonazzi C
Ann Oncol; 1995 Jul; 6(6):571-4. PubMed ID: 8573536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
